Feds Look Into Hospital-Pharma Relations

WITH PHARMACEUTICAL company dollars going into continuing medical education reaching more than $700 million in 2002 (see Data Report, page 11), it should be no surprise that federal scrutiny of how those dollars are spent is also on the rise. While the U.S. Attorney's Office in Boston would not confirm or deny any ongoing investigations, an article in the Boston Globe earlier this summer said that investigators, led mainly by the U.S. Attorney in Boston, were sending out